Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 11
Submit an article Journal homepage
272
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US

Sandra L. Tunis Health Economics and Outcomes Research, IMS Consulting Services, Noblesville, IN, USACorrespondence[email protected]
,
Michael E. Minshall Health Economics and Outcomes Research, IMS Consulting Services, Noblesville, IN, USA
,
Meaghan St. Charles Health Economics and Outcomes Research, IMS Consulting Services, Noblesville, IN, USA
,
Bhavik J. Pandya Takeda Global Research and Development Center, Ltd., Deerfield, IL, USA
&
Robert W. Baran Takeda Global Research and Development Center, Ltd., Deerfield, IL, USA
Pages 3085-3096 | Accepted 27 Aug 2008, Published online: 02 Oct 2008

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Robert G. Masterton, Montserrat Casamayor, Primrose Musingarimi, Anke van Engen, Raymund Zinck, Olatunji Odufowora-Sita & Isaac A. O. Odeyemi. (2013) De-escalation from micafungin is a cost-effective alternative to traditional escalation from fluconazole in the treatment of patients with systemic Candida infections. Journal of Medical Economics 16:11, pages 1344-1356.
Read now
Dong-Churl Suh, Dong-Hyun Lee, Michael McGuire & Chul-Min Kim. (2011) Impact of rosiglitazone therapy on the lipid profile, glycemic control, and medication costs among type 2 diabetes patients. Current Medical Research and Opinion 27:8, pages 1623-1633.
Read now
Meaghan St. Charles, Michael E. Minshall, Bhavik J. Pandya, Robert W. Baran & Sandra L. Tunis. (2009) A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US. Current Medical Research and Opinion 25:6, pages 1343-1353.
Read now

Articles from other publishers (3)

Xinyang Hua, Thomas Wai-Chun Lung, Andrew Palmer, Lei Si, William H. Herman & Philip Clarke. (2016) How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review. PharmacoEconomics 35:3, pages 319-329.
Crossref
Victoria L. Phillips, Ali Bonakdar Tehrani, Holly Langmuir, Patricia S. Goode & Kathryn L. Burgio. (2015) Treating Urge Incontinence in Older Women: A Cost-Effective Investment in Quality-Adjusted Life-Years (QALY). Journal of Geriatrics 2015, pages 1-7.
Crossref
Linda E. Green, Tuan A. Dinh, David A. Hinds, Bryan L. Walser & Richard Allman. (2014) Economic Evaluation of Using a Genetic Test to Direct Breast Cancer Chemoprevention in White Women with a Previous Breast Biopsy. Applied Health Economics and Health Policy 12:2, pages 203-217.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.